Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Gupta, New Delhi
Ajay K. Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20110251839 | METHOD AND SYSTEM FOR INTERACTIVELY FINDING SYNONYMS USING POSITIVE AND NEGATIVE FEEDBACK - Determining synonyms of words in a set of documents. Particularly, when provided with a word or phrase as input, in exemplary embodiments there is afforded the return of a predetermined number of “top” synonym words (or phrases) for an input word (or phrase) in a specific collection of text documents. Further, a user is able to provide ongoing and iterative positive or negative feedback on the returned synonym words, by manually accepting or rejecting such words as the process is underway. | 10-13-2011 |
Ajay Kumar Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20090271383 | METHOD FOR DERIVING CONTEXT FOR DATA DISCLOSURE ENFORCEMENT - Techniques for deriving a context for enforcing a data disclosure policy while accessing a database are provided. The techniques include receiving a request for database access with met a information, parsing the meta information to identify a context, receiving a user query, formulating a query equivalent to-the user query, wherein the equivalent query implements the identified context to enforce a data disclosure policy, and accessing the database with the equivalent query. | 10-29-2009 |
| 20090282493 | MEHTOD AND SYSTEM FOR MANAGING ELECTRONIC MESSAGES - A computer implemented method, computer program product and a data processing system for managing electronic messages is disclosed. The contents of an electronic messages are segmented based on the recipients receiving the message and access control authorizing access to the segmented contents is provided to the segmented contents and transmitted to a list of recipients. | 11-12-2009 |
| 20090282494 | METHOD AND SYSTEM FOR MANAGING ELECTRONIC MESSAGES - A computer implemented method, computer program product and a data processing system for managing electronic messages is disclosed. The contents of an electronic messages are segmented based on the recipients receiving the message and access control authorizing access to the segmented contents is provided to the segmented contents and transmitted to a list of recipients. | 11-12-2009 |
Anil K. Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20090028743 | FORMING MAGNESIUM ALLOYS WITH IMPROVED DUCTILITY - A magnesium alloy comprising up to about one weight percent of cerium may be hot worked to produce an intermediate or final alloy workpiece that exhibits enhanced ductility at room temperature. The addition of a small amount of cerium may affect the magnesium alloy by reducing yield strength, refining grain size, and improving the work hardening behavior. Recrystallization during hot deformation of the rare earth containing magnesium material alters the texture of the alloy and orients the grains in a manner that favors basal slip activity. The alloy thus deforms at room temperature by a combination of twinning and slip mechanisms. | 01-29-2009 |
Anil Kumar Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20080217161 | PROCESS FOR THE SIMULTANEOUS AND SELECTIVE PREPARATION OF SINGLE-WALLED AND MULTI-WALLED CARBON NANOTUBES - The present invention provides a process for the simultaneous and selective growth of single walled and multiwalled carbon nanotubes using electric arc discharge technique. According to present development it is possible to synthesise and collect catalyst free carbon nanotubes from cathode deposit. A mechanism of cooling coil arrangement was designed and used inside the arc discharge chamber so as to be capable to grow sufficient amount of single walled carbon nanotubes in the form of webs surrounding the coil. The present invention offers a scalable way for producing both SWNTs and MWNTs in the single run. | 09-11-2008 |
Anuj Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20110145933 | SYSTEMS AND METHODS FOR SITUATIONAL APPLICATION DEVELOPMENT IN THE ENTERPRISE ENVIRONMENT - Embodiments of the invention broadly contemplate a situational application development framework that provides consumable software components that are accessed as services and monitored in a standardized fashion through a mediator service and thus suitable for use in a controlled development environment. At least one embodiment of the invention thus facilitates on the fly application creation using mashup makers in an enterprise setup. | 06-16-2011 |
Beena Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20090302263 | CONDUCTING COPOLYMER FERROMAGNETIC COMPOSITE AND A PROCESS FOR THE PREPARATION THEREOF - The present invention provides a conducting copolymer ferromagnetic composite. Particularly, the present invention relates to a conducting copolymer of aniline and ethylene-dioxy thiophene containing ferrite particles. The present invention also provides insitu polymerization of aniline and ethylene-dioxy thiophene in the presence of ferrite particles and suitable surfactant medium. This conducting copolymer ferromagnetic composite can be used for the dissipation of electrostatic charge, for the shielding of electromagnetic interference and as absorbing of electromagnetic waves in the microwave region. | 12-10-2009 |
Himanshu Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20100228794 | SEMANTIC DOCUMENT ANALYSIS - A technique for dynamic integration and semantic analysis of structured data and unstructured textual data including: defining and selecting static attributes and dynamic attribute from structured data, embedding static and dynamic views of the selected corresponding attributes in an annotated document, linking the unstructured textual data with the structured data using the defined static and dynamic attributes, populating an annotated document structure of multiple annotated documents, performing semantic analysis of a query across the unstructured textual data and structured data, querying the annotated document structure to provide query results satisfying static part of the query, processing static and dynamic parts of the query by querying structured data and the annotated document structure, as appropriate, and providing a combined query processing result satisfying the dynamic and static part the query. Other embodiments are also disclosed. | 09-09-2010 |
| 20110131216 | AUTOMATICALLY LINKING DOCUMENTS WITH RELEVANT STRUCTURED INFORMATION - A method of associating a given text document with relevant structured data is disclosed. The method receives as inputs a text document, and structured data in the form of a relational database. The method then identifies terms in the text document, and searches and queries the structured data using the terms to identify fragments of the structured data that are relevant to the document. Finally, the text document and the identified fragments of structured data are output to a user. | 06-02-2011 |
| 20110191361 | SYSTEM AND METHOD FOR BUILDING A CLOUD AWARE MASSIVE DATA ANALYTICS SOLUTION BACKGROUND - Embodiments of the invention provide data management solutions that go beyond the traditional warehousing system to support advanced analytics. Furthermore, embodiments of the invention relate to systems and methods for extracting data from an existing data warehouse, storing the extracted data in a reusable (intermediate) form using data parallel and compute parallel techniques over cloud, query processing over the data with/without compute parallel techniques, and providing querying using high level querying languages. | 08-04-2011 |
Manik Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20090220152 | Method and system to detect and quantify blockiness in video files - A method and system for detecting and quantifying blockiness in a video file is disclosed. The video file is a file that has been decompressed by using standard DCT algorithms. The method includes segmenting each frame of the video file into multiple blocks. The method also involves comparing the intensity gradients of each block with one or more threshold values. The one or more threshold values represent predefined intensity variation characteristics. Further, the method includes determining the intensity variation parameters of each block, based on the comparison. Thereafter, a blockiness index is calculated for each block, after which a blockiness value is calculated for each frame. Finally, a blockiness level is assigned to each frame, based on its blockiness value. The blockiness level is a comparative measure of the blockiness of a frame that represents the blockiness content in the frame. | 09-03-2009 |
Mohit Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20090113320 | Method and Apparatus for Generating a Graphical Interface to Enable Local or Remote Access to an Application Having a Command Line Interface - A method and apparatus are disclosed for generating a graphical interface for software applications having a command line interface to enable local or remote access of such software applications in a uniform manner without regard to the location of the remote application. The location and syntax of a new software application, and any required environment settings, are specified in response to a sequence of queries. The specifications for each software application is parsed to generate a graphical client interface listing the available software applications and enabling remote access to such software applications. A desired software application is selected by a user from the client interface and the user specifies any necessary parameters for the selected software application. An input file is transferred from the client to the remote server where the selected software application is located. Any output or log files are returned to the client, for example, using the FTP protocol. The client interface permits distributed processing through a web interface and enables software applications to be accessed and used from a remote location. | 04-30-2009 |
Monika Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20100333069 | STATIC CODE ANALYSIS - Techniques for static code analysis are provided. The techniques include routing a code analysis request to a set of one or more static code analysis tools based on a context of the request, merging one or more tool-specific outputs of the code analysis, wherein merging the one or more tool-specific outputs comprises using one or more tool-specific mappings to one or more static code analysis abstractions and one or more source linkages of one or more static code analysis defects, performing a deep analysis on a set of one or more defect categories, and combining results of the merging with the deep analysis to filter out one or more false-positives and to add one or more new true positives to create an optimal set of defects. | 12-30-2010 |
| 20110029490 | Automatic Checkpointing and Partial Rollback in Software Transaction Memory - While speculatively executing a given one of a plurality of transactions concurrently executing on a computer, carry out write operations in a local data block, and automatically create an entry in a checkpoint log when reading from a shared memory. Continuously conflict check during read and tentative commit operations, and carry out a partial rollback upon detection of a conflict. The partial rollback is based upon the checkpoint log. | 02-03-2011 |
Nidhi Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20090048247 | CONDENSED ISOXALINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE TYPE - IV - The present invention relates to isoxazoline derivatives, which can be used as selective inhibitors of phosphodiesterase (PDE) type IV. In particular, compounds disclosed herein can be useful in the treatment of AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases in a patient, particularly in humans. The present invention also relates to processes for the preparation of disclosed compounds, as well as pharmaceutical compositions thereof, and their use as phosphodiesterase (PDE) type IV inhibitors. | 02-19-2009 |
| 20090306129 | SUBSTITUTED PYRAZOLO [3,4-B] PYRIDINES AS PHOSPHODIESTERASE INHIBITORS - The present invention relates to phosphodiesterase (PDE) type IV selective inhibitors. Processes for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds and their use as PDE type IV selective inhibitors are provided. Prepared compounds correspond to structure XIV Formula (XIV). | 12-10-2009 |
| 20100022571 | SUBSTITUTED PYRAZOLO [3,4-B]PYRIDINES AS PHOSPHODIESTERASE INHIBITORS - The present invention relates to phosphodiesterase (PDE) type IV selective inhibitors. Processes for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds and their use as PDE type IV selective inhibitors are provided. Prepared compounds correspond to structure XIV. | 01-28-2010 |
| 20100029728 | PHOSPHODIESTERASE INHIBITORS - The present invention relates to phosphodiesterase (PDE) type IV selective inhibitors. Compounds disclosed herein can be useful in the treatment of CNS diseases, AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Processes for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and their use as PDE type IV selective inhibitors, are provided. | 02-04-2010 |
| 20100292196 | PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS - The present invention relates to phosphodiesterase (PDE) type 4, phosphodiesterase (PDE) type 7 and dual PDE type 4/PDE type 7 inhibitors. Compounds disclosed herein having the structure of Formula 1: can be useful in the treatment, prevention, inhibition or suppression of CNS diseases, for example, multiple sclerosis; various pathological conditions such as diseases affecting the immune system, including AIDS, rejection of transplant, auto-immune disorders such as T-cell related diseases, for example, rheumatoid arthritis; inflammatory diseases such as respiratory inflammation diseases including chronic obstructive pulmonary disease (COPD), asthma, bronchitis, allergic rhinitis, adult respiratory distress syndrome (ARDS) and other inflammatory diseases including but not limited to psoriasis, shock, atopic dermatitis, eosinophilic granuloma, allergic conjunctivitis, osteoarthritis; gastrointestinal inflammation diseases such as Crohn's disease, colitis, pancreatitis as well as different types of cancers including leukaemia; especially in humans. Processes for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds and their use as PDE type 4, PDE type 7 and dual PDE type 4/PDE type 7 inhibitors are provided. | 11-18-2010 |
| 20110021473 | INHIBITORS OF PHOSPHODIESTERASE TYPE-IV - The present invention relates to catechol derivatives of formula (I), which can be used as inhibitors of phosphodiesterase (PDPI) type 4 or type 7, Compounds disclosed herein can be useful in the treatment of CNS disorders, inflammatory diseases such as, AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and their use as phosphodiesterase (PDE) type 4 or type 7 inhibitors. | 01-27-2011 |
| 20120004201 | PHOSPHODIESTARASE INHIBITORS - The present invention relates to phosphodiesterase (PDE) type 4, phosphodiesterase (PDE) type 7 and dual PDE type 4/PDE type 7 inhibitors. Compounds disclosed herein can be useful in the treatment, prevention, inhibition or suppression of CNS diseases, for example, multiple sclerosis; various pathological conditions such as diseases affecting the immune system, including AIDS, rejection of transplant, auto-immune disorders such as T-cell related diseases, for example, rheumatoid arthritis; inflammatory diseases such as respiratory inflammation diseases including chronic obstructive pulmonary disease (COPD), asthma, bronchitis, allergic rhinitis, adult respiratory distress syndrome (ARDS) and other inflammatory diseases including but not limited to psoriasis, shock, atopic dermatitis, eosinophilic granuloma, allergic conjunctivitis, osteoarthritis; gastrointestinal inflammation diseases such as Crohn's disease, colitis, pancreatitis as well as different types of cancers including leukaemia; especially in humans. Processes for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds and their use as PDE type 4, PDE type 7 and dual PDE type 4/PDE type 7 inhibitors are provided. | 01-05-2012 |
Poornima Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20110191146 | COMPLIANCE METHODOLOGY - Methods, computer readable media, and apparatuses for evaluating compliance with laws, regulations, and/or policies are presented. A metric definition for a metric may be received, the metric measuring an aspect of a business process. The measured aspect may represent a compliance concern. A first sigma score for the metric may be determined based on a number of opportunities and a number of defects. A second sigma score for the business process may be determined. A third sigma score for a business unit may be determined, the business unit implementing the business process. A fourth sigma score for a business segment may be determined, the business segment managing the business unit. A report may be generated, the report including the first sigma score, the second sigma score, the third sigma score, and the fourth sigma score. | 08-04-2011 |
Prabhat Kumar Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20110220577 | PROCESS FOR THE REMOVAL OF ARSENIC AND CHROMIUM FROM WATER - The present invention provides low cost and highly effective method for the removal of arsenic and Cr(III&VI) from contaminated water using zinc peroxide nanoparticles (20±5 nm) capped with glycerol/PVP/TEA upto the permissible range of drinking water. As Arsenic and chromium occurs naturally in the earth's crust. When rocks, minerals, and soil erode, they release arsenic and chromium into groundwater. Arsenic and chromium occurs naturally in varying amounts in groundwater in various parts of country from ppb level to ppm level. The average concentration of arsenic and chromium as per USEPA standard in drinking water it is 10 parts per billion and 0.05 ppm (50 ppb) respectively. In drinking water the level of chromium is usually low as well, but contaminated water may contain the dangerous Cr(III&VI). Although Cr(III) is an essential nutrient for humans and shortages may cause heart problems, disruptions of metabolisms and diabetes. But the uptake of too much Cr(III) can cause health effects as well, for instance skin rashes. Cr(VI) is known to cause various health effects Skin rashes, upset stomachs, respiratory problems, weakened immune systems, kidney and liver damage and lung cancer The persons who are drinking water having upto 50 ppb of arsenic and 0.05 ppm chromium over for many years could experience skin damage or problems with their circulatory system, and may have an increased risk of getting cancer. Keeping the above facts we developed a cost effective nanoparticles for the removal of Arsenic and Cr(III&VI) from potable water upto potable range. | 09-15-2011 |
Ritesh Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20110282800 | GLOBAL MANUFACTURING STRATEGY OPTIMIZATION TOOL - Embodiments of the present invention provide for a seamless comparison of different global manufacturing strategies. In a specific embodiment of the invention, a computer-implemented method for analyzing a manufacturing scenario for an enterprise is provided. This method comprises a step of inputting a set of key cost inputs. The method additionally comprises a step of adjusting a set of manufacturing scenario levers to create a set of manufacturing scenario inputs. The method additionally comprises a step of synthesizing a scenario for simulation based on said set of manufacturing scenario inputs. The method additionally comprises a step of obtaining a result of said scenario for said enterprise by simulating said scenario using said key cost inputs. | 11-17-2011 |
Sarika Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20090258818 | Compositions For the Treatment of Diabetes - A supramolecular insulin assembly and supramolecular exendin-4 assembly, which is useful as a protein therapeutic agent for the treatment of metabolic disorders particularly diabetes. The supramolecular assemblies disclosed in the present invention consists of insoluble and aggregated oligomers the protein. The invention also provides pharmaceutical compositions comprising the supramolecular assembly. | 10-15-2009 |
| 20110034385 | Compositions Useful for the Treatment of Diabetes and Other Chronic Disorder - The present invention provides a supramolecular protein assembly useful as a protein therapeutics for the treatment of metabolic disorders particularly diabetes. The supramolecular protein assembly disclosed in the present invention consists of insoluble and aggregated oligomers the protein. The invention also provides pharmaceutical compositions comprising supramolecular protein assembly. The composition disclosed in the present invention particularly comprises supramolecular insulin assembly. | 02-10-2011 |
Savi Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20120095929 | Method and system for selecting and filing intellectual property application in multiple countries - A system and method enables Intellectual Property (IP) applicants to determine the target countries for filing an IP application and provides filing and formalities support. The method includes generating a comprehensive list of target countries, eliminating countries based on patentability laws, prioritising the remaining list of countries on IP and market-specific factors, and filtering the list based on the filing cost in each country and the applicant's IP filing budget. | 04-19-2012 |
Suresh Kumar Gupta, New Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20090175972 | Synergistic herbal ophthalmic formulation for lowering intraocular pressure in case of glaucoma - The present invention relates to an herbal ophthalmic composition of | 07-09-2009 |
| 20100112106 | SYNERGISTIC HERBAL OPHTHALMIC FORMULATION FOR LOWERING THE INTRA OCULAR PRESSURE IN CASE OF GLAUCOMA - The present invention relates to a synergistic herbal composition for lowering the intra ocular pressure in different types of glaucoma and process for the preparation of the same in pharmaceutically acceptable dosage forms. | 05-06-2010 |
| 20100203178 | SYNERGISTIC HERBAL COMPOSITION - A present invention relates to the synergistic herbal ophthalmic composition, which delays the onset and progression of cataract. The product is suitable for prophylactic treatment of cataract of different degree. The herbs are cleaned coarsely ground, weighed as per formula and extracted using different solvents preferably water, filtered or centrifuged to collect the clear filtrate and formulated in the form of sterile ophthalmic drops, gel, ointment, cream etc for said therapeutic purpose. | 08-12-2010 |